Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/9/2021
CANbridge Pharma Launches IPO on the Main Board of Hong Kong Stock Ex...
12/9/2021
Simcere Pharma and Immunophage Gain Three New Drug IND Approvals in Ch...
12/9/2021
China Extends Crackdown of BMI Frauds for Another Year
12/8/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (49th ...
12/8/2021
CDE Issues the Technical Guidelines for Clinical Trials of Weight Cont...
12/8/2021
CDE Issues Three Preclinical Guidance Documents for Covid-19 Drugs
12/8/2021
CDE Issues the Technical Guidelines for Application of Biomarkers in C...
12/8/2021
CDE Solicits Comments on the Technical Guidelines for Clinical Evaluat...
12/8/2021
CDE Solicits Comments on the Technical Guidelines for Endpoints in Adv...
12/8/2021
Shanghai Pharma and Syntegon Partner to Promote Continuous Manufacturi...
12/8/2021
China Approves Brii Biosciences' COVID-19 Treatment
12/8/2021
Three Chinese Biopharma Firms to Start Producing Russian Covid-19 Vacc...
12/7/2021
Sanofi Scores A Trademark Win in China
12/6/2021
Ji Xing Completes P1 Study of Aficamten, A Potential Next-Gen Cardiac...
12/6/2021
Junshi Granted Chinese sNDA Approval for Toripalimab in Combo with Cis...
12/6/2021
Rhythm Enters Licensing Deal with RareStone to Commercialize Rare Obes...
12/6/2021
SoftBank Reportedly in Investment Talks with Chinese mRNA Vaccine Firm...
12/6/2021
Fujifilm Irvine Scientific Establishes Innovation Center in China
12/6/2021
Chinese Official A 'Hero' After Forcing Biogen to Cut Cost of Treatmen...
12/6/2021
Maximizing China Access for Innovative Therapies (PharmExec)
12/6/2021
Snapshot of the 67 Novel Drug Products Included in the 2021 NRDL Thru ...
12/5/2021
China Made Solid Reform and Regulatory Advances on Multiple Fronts Las...
12/5/2021
Biogen's Spinraza, Fosun-Kite's Yescarta and A Controversial Alzheimer...
12/5/2021
Innovent and Lilly Announce Successful Expansion of Sintilimab in Chin...
12/3/2021
FDA Rejects BeyondSpring's NDA for Neutropenia Therapy
12/3/2021
BeiGene and EUSA Announce CN Approval of SYLVANT (Siltuximab for Inje...
12/3/2021
CDE Issues the Technical Guidelines for Long Term Follow-up Clinical R...
12/3/2021
CDE Issues Two Technical Guidelines for Non-clinical Research and Asse...
12/3/2021
Recent Executive Moves
12/2/2021
NMPA Solicits Comments on the Draft Guidelines for Pharmacovigilance I...
Page:
102
/
719
Total number of articles:
21546
:
[First]
[<<]
[100]
[101]
[102]
[103]
[104]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit